We found that TM4SF5 expression could override CD151 functions, and TM4SF5 acted antagonistically to CD63 during liver fibrosis development and during hepatic migration/invasive extracellular matrix (ECM) -degradation. The gene discussed is TM4SF5; the disease is Hepatic fibrosis.